Press release
C-Reactive Protein (CRP) Testing Market to Surpass USD 2.9 Billion by 2034
C-Reactive Protein (CRP) Testing
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50072
Key Takeaways
• Market value: USD 1.7 billion (2024) → USD 2.9 billion (2034) | CAGR: 5.8%
• Major applications: Cardiovascular disease risk evaluation, infection and inflammation detection, rheumatoid arthritis monitoring, and post-surgical assessments.
• Technology leaders: Immunoturbidimetric and ELISA methods dominate; high-sensitivity CRP (hs-CRP) gaining strong traction for preventive cardiology.
• Regional highlights: North America leads global share; Asia Pacific expected to grow fastest due to expanding healthcare infrastructure and awareness initiatives.
• Key challenge: Cost of advanced assays in developing regions and limited awareness of preventive testing.
Market Story
C-reactive protein testing has evolved from a niche diagnostic into a mainstream biomarker tool for assessing systemic inflammation. Rising global burden of chronic conditions - including cardiovascular diseases, autoimmune disorders, diabetes, and infections - is boosting CRP testing demand. Moreover, increased adoption of hs-CRP assays enables early prediction of heart attack and stroke risk, supporting preventive cardiology programs.
Technological advances in immunoassay platforms, point-of-care devices, and automated analyzers have made testing faster, more sensitive, and more accessible. Leading manufacturers are integrating CRP testing with multi-biomarker panels, enabling physicians to correlate inflammatory profiles with patient outcomes in real time.
Meanwhile, the growing popularity of home-based sample collection and digital diagnostics post-COVID-19 further supports CRP testing market expansion.
Segments Covered
• By Assay Type: Immunoturbidimetric assay, ELISA assay, High-Sensitivity CRP (hs-CRP) assay, Others
• By Application: Infection Detection, Cardiovascular Disease Risk Assessment, Rheumatoid Arthritis Monitoring, Inflammatory Bowel Disease, Others
• By End User: Hospitals & Clinics, Diagnostic Laboratories, Academic Institutions, Home Care Settings
• By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/50072/c-reactive-protein-testing-market
Recent Developments
• Siemens Healthineers and Abbott Laboratories launched upgraded high-sensitivity CRP testing kits compatible with fully automated analyzers.
• Thermo Fisher Scientific expanded its cardiovascular biomarker panel portfolio with integrated hs-CRP solutions.
• Beckman Coulter introduced a cost-efficient immunoassay line targeted at emerging markets to enhance accessibility.
• Strategic collaborations between diagnostic labs and telehealth providers now enable at-home CRP testing and real-time physician consultation.
Expert Quote
"The CRP Testing Market is entering a preventive-diagnostics era. With high-sensitivity CRP assays now part of routine wellness panels, healthcare providers can identify cardiovascular risk earlier and improve patient outcomes," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy. "The next decade will witness widespread adoption of AI-driven interpretation and personalized inflammation profiling."
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50072
Market Drivers
• Rising global incidence of chronic inflammatory & autoimmune disorders
• Growing emphasis on preventive healthcare and cardiovascular screening
• Integration of CRP testing into multi-biomarker diagnostic panels
• Expansion of point-of-care testing and home diagnostics
• Continuous technological innovation and automation in immunoassay systems
Forecast & Regional Insights
North America will remain the largest revenue contributor, owing to strong presence of leading diagnostic companies, high healthcare expenditure, and established laboratory infrastructure. Europe follows closely with increasing adoption of hs-CRP testing in clinical risk assessments.
Asia Pacific is set to record the fastest CAGR, driven by government healthcare reforms, broader insurance coverage, and surging public awareness. Meanwhile, Latin America and the Middle East & Africa will benefit from growing private diagnostic chains and partnerships for affordable testing solutions.
Conclusion
The C-Reactive Protein Testing Market is evolving into a cornerstone of modern diagnostics - bridging infection management, cardiovascular risk analysis, and chronic-disease surveillance. As preventive medicine gains prominence, companies investing in accessible, automated, and accurate CRP testing platforms will capture substantial value through 2034.
This report is also available in the following languages : Japanese (C反応性タンパク質検査市場), Korean (C 반응성 단백질 테스트 시장), Chinese (C反应蛋白检测市场), French (Marché des tests de protéine C-réactive), German (Markt für C-reaktives Protein-Tests), and Italian (Mercato dei test sulla proteina C reattiva), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50072/c-reactive-protein-testing-market#request-a-sample
Related Reports
Ophthalmic Silicone Oil Market
https://exactitudeconsultancy.com/reports/60713/global-ophthalmic-silicone-oil-market
Fluorescein Sodium Ophthalmic Strip Market
https://exactitudeconsultancy.com/reports/60751/global-fluorescein-sodium-ophthalmic-strip-market
Multi-Dose Eye Dropper Market
https://exactitudeconsultancy.com/reports/61884/global-multi-dose-eye-dropper-market
Ophthalmic Surgical Microscope Market
https://exactitudeconsultancy.com/reports/62197/global-ophthalmic-surgical-microscope-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release C-Reactive Protein (CRP) Testing Market to Surpass USD 2.9 Billion by 2034 here
News-ID: 4266913 • Views: …
More Releases from Exactitude Consultancy
Liver Health Supplements Market Poised for Strong Growth Through 2034
The global liver health supplements market is set to expand markedly over the 2024-2034 period, according to the latest analysis by Exactitude Consultancy. With an estimated market size of around US $0.9 billion in 2024, the market is projected to reach about US $1.9 billion by 2034-representing a compound annual growth rate (CAGR) of roughly 6.9%. The report examines growth drivers, market segmentation, regional dynamics, key players, and future opportunities…
Neurorehabilitation Gaming Systems Market to Reach USD 1.72 Billion by 2034
Pune, India, November 2025 - According to the latest report by Exactitude Consultancy, the Global Neurorehabilitation Gaming Systems Market is valued at USD 770 million in 2024 and is projected to reach USD 1.72 billion by 2034, growing at an impressive CAGR of 8.4% from 2025 to 2034. Increasing incidence of stroke, Parkinson's disease, and traumatic brain injury (TBI), coupled with technological innovation in virtual and augmented reality therapies, is…
Oral Doxycycline Hyclate Market Set to Grow Rapidly Through 2034
The global oral doxycycline hyclate market is poised for meaningful growth between 2024 and 2034, according to the latest study by Exactitude Consultancy. With an estimated market size of ~US $1.5 billion in 2024, the market is projected to reach approximately US $2.4 billion by 2034, representing a compound annual growth rate (CAGR) of around 5.1% over the forecast period. The report covers market dynamics, regional outlook, product and application…
Cutaneous B-Cell Lymphoma Treatment Market to Reach USD 2.73 Billion by 2034
The global Cutaneous B-Cell Lymphoma (CBCL) Treatment Market is projected to grow from USD 1.68 billion in 2024 to approximately USD 2.73 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.0% during the forecast period. The market's trajectory is defined by an increasing burden of lymphoproliferative disorders, rapid progress in immuno-oncology, and the introduction of targeted biologics such as rituximab, brentuximab vedotin, and next-generation anti-CD20 monoclonal…
More Releases for CRP
Finalized the ITT investment in CRP Technology and CRP USA
Modena, Italy, June 16th, 2022 - 3D printing leading companies CRP Technology and CRP USA have signed an investment agreement with ITT Inc., a diversified leading manufacturer of highly engineered critical components and customized technology solutions headquartered in Stamford, Connecticut (USA) and present in more than 35 countries.
According to the operation, ITT Inc. becomes part of the shareholder structure of CRP Technology and CRP USA, in line with its business…
CRP USA is AS9100 certified
CRP USA, pioneering company in the fields of Additive Manufacturing and high performance composite materials, announced it has recently achieved AS9100 Rev. D certification for the manufacture of 3D printed aerospace products from its customer's component design data.
AS9100 Rev. D certification signifies CRP USA’s ongoing commitment to meeting and exceeding increasingly stringent industry requirements for aerospace related products.
"We have taken our expertise in Additive Manufacturing solutions to new heights to…
CRP Technology shines at Sachsenring racetrack
Positive debut for the Italian-based companies and Energica’s technological partners for MotoE
CRP Technology and CRP Meccanica made their debut at Sachsenring racetrack during the inaugural weekend of MotoE (5 – 7 July 2019) as Energica technological partners.
The series had been stopped due to the Jerez fire but thanks to the hard work of Energica team and the partners involved, all Ego Corsa motorcycles were rebuilt in less than three months.
The…
CRP Technology is part of ARTES 4.0
CRP's cutting-edge AM technologies at the service of the most innovative projects in the field of Advanced Robotics
CRP Technology participates as an affiliated member to ARTES 4.0 association (Advanced Robotics and enabling digital TEchnologies & Systems 4.0).
The new born association leads the homonymous Competence Center coordinated by the Scuola Superiore Sant’Anna, and it is characterized as a partnership that connect universities, research institutes and companies focused on innovation.
ARTES 4.0 Competence…
MotoE™ ready to race thanks to CRP Meccanica and CRP Technology
Preparations are in progress for the resumption of the activities of the FIM Enel MotoE ™ World Cup after the setback last March, when a fire in Jerez destroyed much of the material for the MotoE™ , Ego Corsa machines included.
CRP Technology and CRP Meccanica did not fail to give Energica (the FIM Enel MotoE ™ World Cup single manufacturer) their support on a par with the commitment made…
CRP USA at AeroDef Manufacturing 2019
Stewart Davis, Director of Operations at CRP USA , will be attending AeroDef Manufacturing as speaker.
The 2019 edition will be held from 29th April to 2nd May, 2019, at Long Beach Convention Center, Long Beach, California.
At the 2019 edition Stewart Davis will be presenting the paper: “TuPOD, Cube Satellite and Tube Satellite dispenser produced via 3D Printing, successful launch orbit and dispensing of Two TubeSat”.
The speech is set for…
